Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Dades bibliogràfiques
Autor principal:	Mirza, Maisa Tasnim
Altres autors:	Jamiruddin, Dr. Mohd. Raeed
Format:	Thesis
Idioma:	English
Publicat:	Brac University 2023
Matèries:	Aromatase inhibitors Breast cancer Ductal carcinoma in situ Estrogen receptor positive Hormonal therapy Tamoxifen. Breast > Cancer > Chemoprevention.
Accés en línia:	http://hdl.handle.net/10361/18147

Ítems similars

Breast cancer awareness seminars
per: Anwer Khan Modern Medical College
Publicat: (2016)

Recent advancement on breast cancer detection and treatment
per: Rahman, Sanjida
Publicat: (2023)

Natural products and their combinatory effects in breast cancer treatment
per: Siddique, Md. Ayman
Publicat: (2021)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
per: Shobnam, Sohana
Publicat: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
per: Alam, Kazi Tasnuva
Publicat: (2022)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
per: Raihan, Dilraj
Publicat: (2024)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
per: Akter, Honufa
Publicat: (2024)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
per: Iqbal, Mohammad Shamim, et al.
Publicat: (2017)

The impact of breast cancer on women’s lives in Bangladesh
per: Mobashera, Tayeeba Tum
Publicat: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
per: Chakraborty, Anuradha
Publicat: (2024)

A review on triple-negative breast cancer and its potential treatment
per: Niasa, Jannatul Ferdous
Publicat: (2023)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
per: Araf, Faiaz Fahim
Publicat: (2024)

Machine learning as an indicator for breast cancer prediction
per: Shadman, Tahsin Mohammed, et al.
Publicat: (2019)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
per: Nuha, Nabiha Tahsin
Publicat: (2024)

Breast cancer therapy through Liposomal drug delivery system
per: Ome, Nusrat Jahan
Publicat: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
per: Lamia
Publicat: (2020)

Early detection of breast cancer using machine learning
per: Fuad, Wasi Mohammad
Publicat: (2019)

Breast cancer in South Asia: a Bangladeshi perspective
per: Hossain, Mohammad Sorowar, et al.
Publicat: (2017)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
per: Parvin, Salma, et al.
Publicat: (2016)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
per: Oishy, Jannatun Noor
Publicat: (2024)

Breast cancer prediction using different machine learning models
per: Khandker Al- Muhaimin, et al.
Publicat: (2020)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
per: Bristy, Israt Zerin
Publicat: (2021)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
per: Hasan, Sakib
Publicat: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
per: Monayem, Kazi Fahim
Publicat: (2024)

Exploring the use of Ingenol Mebutate to prevent non-melanoma skin cancer: A review
per: Haque, Fariha
Publicat: (2023)

Machine learning In breast cancer prognosis and prediction
per: Chowdhury, Shah Abul Hasnat, et al.
Publicat: (2023)

Elucidating the functional roles of bidirectionally transcribed genes in immunobiology of cancers
per: Ahmad, Sheikh Shafin
Publicat: (2021)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
per: Rahman, Sanjida
Publicat: (2024)

Statistics and informatics in molecular cancer research

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
per: Karim, Azrin
Publicat: (2024)

Immunotherapy in the treatment of renal cancer
per: Shimu, Sumaya
Publicat: (2022)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
per: Chowdhury, Maisha Mosharrat
Publicat: (2018)

Cancer risk factors: a critical review
per: Tabassum, Tahsina
Publicat: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
per: Nawar, Anika
Publicat: (2019)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
per: Zangmo, Thinley
Publicat: (2024)

Application of deep convolutional neural network in breast cancer prediction using Digital Mammograms
per: Al Mamun, Rafsan, et al.
Publicat: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
per: Abir, Shifaty Nur
Publicat: (2024)

Targeting BRAFV600E in the treatment of CRC
per: Roja, Mashwiyat Samrin
Publicat: (2024)

Role of statins as antagonists of SPARC in gastric cancer
per: Shahmat, Rad
Publicat: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
per: Pial, Sazia Afrin
Publicat: (2018)